Alteogen Announces Exclusive License Agreement with Tesaro for the Development of a SQ Formulation of Dostarlimab Enabled by Hybrozyme™ Technology January 26, 2026
Infinitopes Expands Seed Financing to $35M to Accelerate Clinical Development of Precision Cancer Vaccine January 26, 2026
